You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – PerkinElmer reduced its number of employees by 72 as part of a restructuring plan during its recently completed second quarter, the company disclosed this week.
German molecular diagnostics firm Epigenomics today reported that its first-half revenues increased 1 percent year over year, and the firm is implementing a restructuring that will include cutting its staff by nearly half.
As part of the restructuring, Silence has lowered the headcount at its Berlin research facility to 27 from 32.
Silence said that the offering, if completed, would extend its cash runway from the third quarter of this year until mid-2012.
Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.
The Australian gel and protein detection firm sold its US subsidiary and its flagship technology in recent months and is now targeting acquisitions moving ahead.
Collins' "bold" plan to break up NCRR to catalyze translational science is drawing fire over its process and its plans for NCRR, as well as notes of caution from seasoned senators.
It was not immediately clear what impact the move would have on the programs overseen by the unit.
An article about an acquisition topped the list of the most-read stories for the year on GenomeWeb Daily News, while restructurings, lawsuits, and one firm's IPO plans made it into the top 10.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.